These results, along with a earlier report exhibiting that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like conduct in mice,2 guidance the strategy of targeting ACKR3 as a unique method to modulate the opioid process, which could open up new therapeutic avenues for opioid-relevant disorders. At that point, Microsoft Advertising https://englandu825mzb5.wikisona.com/user